These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1797157)

  • 21. [Results of using a simple cybernetic method for the evaluation of the information capacity of several biochemical tests in chronic diffuse liver diseases].
    Bliuger AF; Krupnikova EZ; Golubev IS; Raĭtsis AB
    Ter Arkh; 1969; 41(10):81-5. PubMed ID: 5359353
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of different modifications of the bromsulphalein test].
    Hennecke A; König KJ
    Dtsch Med Wochenschr; 1973 May; 98(18):934-7. PubMed ID: 4700738
    [No Abstract]   [Full Text] [Related]  

  • 23. [Quantitative immunoglobulin determinations in serum in inflammatory liver diseases. 3. Correlation with inflammation reaction in the histological picture].
    Gleichmann E; Wepler W; Otto P; Deicher H
    Acta Hepatosplenol; 1970; 17(4):255-73. PubMed ID: 4101356
    [No Abstract]   [Full Text] [Related]  

  • 24. [Scintigraphic diagnosis and laboratory values in diffuse liver parenchyma diseases].
    Deininger HK; Heuck F
    Fortschr Geb Rontgenstr Nuklearmed; 1971 Jan; 114(1):108-19. PubMed ID: 5099736
    [No Abstract]   [Full Text] [Related]  

  • 25. The effect of acute liver damage on circulating ferritin levels in vivo and in the isolated perfused rat liver.
    Mack U; Owens J; Cooksley WG; Powell LW; Halliday JW
    Br J Exp Pathol; 1985 Apr; 66(2):185-91. PubMed ID: 3986131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum bile acids and rountine liver function tests in patients with chronic liver disease and cholestasis.
    Collins DM; Tongeren AV; Cook HB; Campbell CB
    N Z Med J; 1979 Jun; 89(637):432-4. PubMed ID: 289016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic usefulness of plasma carcinoembryonic antigen levels in acute and chronic liver disease.
    Bullen AW; Losowsky MS; Carter S; Patel S; Neville AM
    Gastroenterology; 1977 Oct; 73(4 Pt 1):673-8. PubMed ID: 892370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on the effect of liver cytosol on experimental acute hepatic failure in the rat].
    Ha TZ
    Zhonghua Yi Xue Za Zhi; 1989 May; 69(5):267-70, 18. PubMed ID: 2804738
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatocellular transplantation for treatment of D-galactosamine-induced acute liver failure in rats.
    Sommer BG; Sutherland DE; Matas AJ; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):578-84. PubMed ID: 377697
    [No Abstract]   [Full Text] [Related]  

  • 30. [Advances in the field of liver diseases].
    Strohmeyer G
    Z Gastroenterol; 1972; 10(1):2-16. PubMed ID: 4603325
    [No Abstract]   [Full Text] [Related]  

  • 31. [Modelling of acute liver failure in rabbits].
    Farber NA; Ketiladze ES; Gubskiĭ LV; Erokhina LG; Braginskiĭ DM
    Biull Eksp Biol Med; 1982 Jun; 93(6):41-5. PubMed ID: 7115932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].
    Pagani A; Zigliani P; Pranzo A; Galante T
    Minerva Med; 1992 Nov; 83(11):715-20. PubMed ID: 1461542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gamma-glutamyl-transpeptidase activity in liver diseases].
    Eisenberg K; Ortmans H
    Med Klin; 1973 Jun; 68(24):798-804. PubMed ID: 4724026
    [No Abstract]   [Full Text] [Related]  

  • 34. [Acute and chronic hepatic disorders].
    Shikata T
    Nihon Rinsho; 1972 Jan; 30(1):207-10. PubMed ID: 4556873
    [No Abstract]   [Full Text] [Related]  

  • 35. [The effect of prednisolone on the development of the galactosamine hepatitis of young and old rats (author's transl)].
    Platt D; Leinweber B; Förster L; Förster K
    Aktuelle Gerontol; 1976 Jun; 6(6):267-78. PubMed ID: 14531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The oral galactose tolerance as a liver function test. Clinical-experimental studieson the prolem of dosage].
    Rommel K; Grimmel K
    Med Klin; 1967 Feb; 62(5):168-71. PubMed ID: 5590185
    [No Abstract]   [Full Text] [Related]  

  • 37. [Xanthine oxidase and uricase activities in some conditions of human and experimental hepatic pathology].
    Galanti B; Giusti G; Mancini A
    Boll Soc Ital Biol Sper; 1965 Dec; 41(24):1563-6. PubMed ID: 5878187
    [No Abstract]   [Full Text] [Related]  

  • 38. Fetal liver allo- and xenotransplantation in acute and chronic hepatic failure.
    Sano N; Matsuno N; Sugimoto A; Seiki K; Tsuji K
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2360-1. PubMed ID: 2652767
    [No Abstract]   [Full Text] [Related]  

  • 39. The incidence of oxyphenisatin-induced liver damage in chronic non-alcoholic liver disease. A controlled investigation.
    Dietrichson O; Juhl E; Nielsen JO; Oxlund JJ; Christoffersen P
    Scand J Gastroenterol; 1974; 9(5):473-8. PubMed ID: 4605276
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatic scintiscanning in fulminant hepatic failure.
    Murray-Lyon IM; Davidson AR; Rake MO; Osborn SB; Williams R
    Br J Radiol; 1973 Jan; 46(541):30-3. PubMed ID: 4683327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.